Skip to main content Back to Top
Advertisement

2/29/2024

Minoxidil 2.5 mg Tablets

Products Affected - Description

    • Minoxidil oral tablet, Sun Pharma, 2.5 mg, bottle, 100 count, NDC 53489-0386-01
    • Minoxidil oral tablet, Teva, 2.5 mg, bottle, 100 count, NDC 00591-5642-01

Reason for the Shortage

    • Sun did not provide a reason for the shortage.
    • Par has minoxidil available.
    • Teva did not provide a reason for the shortage.
    • Minoxidil 10 mg tablets are not affected by the shortage.

Available Products

    • Minoxidil oral tablet, Par Pharmaceuticals, 2.5 mg, bottle, 100 count, NDC 49884-0256-01

Estimated Resupply Dates

    • Sun has minoxidil 2.5 mg tablets on intermittent back order and the company is releasing supplies as they become available.
    • Teva has minoxidil 2.5 mg tablets on intermittent back order and the company is releasing supplies as they become available.

Updated

Updated February 29, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. Created November 29, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

ADVERTISEMENT

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.